management of neonatal sepsis niki kosmetatos, md anthony piazza, md j. devn cornish, md emory...
TRANSCRIPT
Management of Management of Neonatal SepsisNeonatal Sepsis
Niki Kosmetatos, MDNiki Kosmetatos, MD
Anthony Piazza, MDAnthony Piazza, MD
J. Devn Cornish, MDJ. Devn Cornish, MD
Emory UniversityEmory University
Department of PediatricsDepartment of Pediatrics
IncidenceIncidence MortalityMortality
– 13-69% world wide13-69% world wide– 13-15% of all neonatal deaths (US)13-15% of all neonatal deaths (US)
MeningitisMeningitis– 0.4-2.8/1000 live births (US 0.2-0.4/1000)0.4-2.8/1000 live births (US 0.2-0.4/1000)– Mortality 13-59%; US 4% of all neonatal Mortality 13-59%; US 4% of all neonatal
deathsdeaths SepsisSepsis
– 1-21/1000 world wide; US1-8/1000 live 1-21/1000 world wide; US1-8/1000 live birthsbirths
– Culture proven 2/1000 (3-8% of infants Culture proven 2/1000 (3-8% of infants evaluated for sepsis)evaluated for sepsis)
– Prematures Prematures <1000 g <1000 g 26/1000 26/1000 1000 - 2000 g 1000 - 2000 g 8-8-
9/10009/1000
Predisposing FactorsPredisposing FactorsGeneral Host FactorsGeneral Host Factors PrematurityPrematurity Race – GBS sepsis blacks>whitesRace – GBS sepsis blacks>whites Sex – sepsis & meningitis more common Sex – sepsis & meningitis more common
in males, esp. gram negative infectionsin males, esp. gram negative infections Birth asphyxia, meconium staining, stressBirth asphyxia, meconium staining, stress Breaks in skin & mucous membrane Breaks in skin & mucous membrane
integrity integrity (e.g. omphalocoele, meningomyelocoele)(e.g. omphalocoele, meningomyelocoele)
Environmental exposureEnvironmental exposure Procedures Procedures (e.g. lines, ET-tubes)(e.g. lines, ET-tubes)
Predisposing FactorsPredisposing Factors Maternal/Obstetrical FactorsMaternal/Obstetrical Factors
GeneralGeneral – – socioeconomic status, poor prenatal socioeconomic status, poor prenatal care, vaginal flora, maternal substance abuse, care, vaginal flora, maternal substance abuse, known exposures, known exposures, prematurityprematurity, twins, twins
Maternal infectionsMaternal infections – –chorioamnionitis (1-10% of chorioamnionitis (1-10% of pregnancies), fever (>38° C/100.4° F), sustained pregnancies), fever (>38° C/100.4° F), sustained fetal tachycardia, venereal diseases, fetal tachycardia, venereal diseases, UTI/bacteriuria, foul smelling lochia, GBS+, other UTI/bacteriuria, foul smelling lochia, GBS+, other infectionsinfections
Obstetrical manipulationObstetrical manipulation – – amniocentesis, amniocentesis, amnioinfusion, prolonged labor, fetal monitoring, amnioinfusion, prolonged labor, fetal monitoring, digital exams, previa/abruption?digital exams, previa/abruption?
Premature & Prolonged ROM, preterm laborPremature & Prolonged ROM, preterm labor
Predisposing FactorsPredisposing Factors
Overall sepsis rateOverall sepsis rate 8/10008/1000
Maternal FeverMaternal Fever 4/10004/1000
PROMPROM 10-13/100010-13/1000
Fever & PROMFever & PROM 87/100087/1000
Preterm Labor/PROMPreterm Labor/PROM
Prematurity Prematurity (~10%) 15-25% due to (~10%) 15-25% due to maternal infectionmaternal infection
>18-24h term; >12-18h preterm>18-24h term; >12-18h preterm Bacterial infectionBacterial infection
synthesis of PGsynthesis of PG– Macrophage TNF/IL stimulate PG Macrophage TNF/IL stimulate PG
synthesis, cytokine releasesynthesis, cytokine release****– Release of collagenase & elastase Release of collagenase & elastase
ROMROM + Amniotic fluid cultures 15% + Amniotic fluid cultures 15% (with (with
intact membranes)intact membranes)
SSEPSISEPSIS
ORGANISMSORGANISMS Group B strep Group B strep (most common G+)(most common G+)
Coliforms Coliforms (E. coli most common G-)(E. coli most common G-)
ListeriaListeria Nosocomial infectionsNosocomial infections Staph epidermidisStaph epidermidis CandidaCandida Note: 50% G+ and 50% G-Note: 50% G+ and 50% G-
Routes of InfectionRoutes of Infection
Transplacental/HematogenousTransplacental/Hematogenous Ascending/Birth CanalAscending/Birth Canal NosocomialNosocomial
Transplacental/Transplacental/HematogenousHematogenous Organisms (Not just “TORCHS”)Organisms (Not just “TORCHS”)
SyphilisSyphilis Herpes*Herpes*ToxoplasmosisToxoplasmosis GonorrheaGonorrheaRubellaRubella MumpsMumpsCytomegalovirusCytomegalovirus TBTBAcute VirusesAcute Viruses HIVHIV
CoxsackieCoxsackie PolioPolioAdenovirusAdenovirus GBSGBSEchoEcho MalariaMalariaEnterovirusEnterovirus LymeLyme
VaricellaVaricellaParvovirus*Parvovirus*
Ascending/Birth CanalAscending/Birth Canal
Organisms - GI/GU flora, Organisms - GI/GU flora, Cervical/BloodCervical/Blood
E. Coli E. Coli HerpesHerpes
GBSGBS CandidaCandida
ChlamydiaChlamydia HIVHIV
UreaplasmaUreaplasma MycoplasmaMycoplasma
ListeriaListeria HepatitisHepatitis
EnterococcusEnterococcus AnaerobesAnaerobes
GonorrheaGonorrhea SyphilisSyphilis
HPVHPV
NosocomialNosocomial Organisms – Organisms –
Skin Flora, Equipment/Environment Skin Flora, Equipment/Environment Staphylococcus – Coagulase neg & posStaphylococcus – Coagulase neg & posMRSAMRSAKlebsiellaKlebsiellaPseudomonas/ProteusPseudomonas/ProteusEnterobacterEnterobacterSerratiaSerratiaRotavirusRotavirusClostridia – C dificileClostridia – C dificileFungiFungi
InfectionInfection
TimingTiming
OnsetOnset– Early OnsetEarly Onset 1 1stst 24 hrs 24 hrs 85 %85 %
24-48 hrs24-48 hrs5%5%
– Late OnsetLate Onset 7-90 days 7-90 days
SymptomsSymptoms Non-specific/Common Non-specific/Common
– Respiratory distress Respiratory distress (90%)(90%) - - RR, apnea RR, apnea (55%), (55%),
hypoxia/vent need hypoxia/vent need (36%), (36%), flaring/gruntingflaring/grunting
– Temperature instability, feeding problemsTemperature instability, feeding problems– Lethargy-irritability Lethargy-irritability (23%)(23%)
– Gastrointestinal – Gastrointestinal – poor feeding, vomiting, poor feeding, vomiting, abdominal distention, ileus, diarrheaabdominal distention, ileus, diarrhea
– Color—Color—Jaundice, pallor, mottlingJaundice, pallor, mottling
– Hypo- or hyperglycemiaHypo- or hyperglycemia– Cardiovascular – Cardiovascular – HypotensionHypotension (5%), (5%),
hypoperfusion, tachycardiahypoperfusion, tachycardia– Metabolic acidosisMetabolic acidosis NICHD dataNICHD data
SymptomsSymptoms Less commonLess common
– SeizuresSeizures– DICDIC– PetechiaePetechiae– HepatosplenomegalyHepatosplenomegaly– ScleremaSclerema
Meningitis symptomsMeningitis symptoms– Irritability, lethargy, poorly responsiveIrritability, lethargy, poorly responsive– Changes in muscle tone, etc.Changes in muscle tone, etc.
EvaluationEvaluation Non-specific Non-specific
– CBC/diff, platelets – ANC, I/T ratioCBC/diff, platelets – ANC, I/T ratio– RadiographsRadiographs– CRPCRP– Fluid analysis – LP, Fluid analysis – LP, U/A U/A – Glucose, lytes, gasesGlucose, lytes, gases
Specific – Cultures, stainsSpecific – Cultures, stains Other – immunoassays, PCR, DNA Other – immunoassays, PCR, DNA
microarraymicroarray
Results “Trigger Results “Trigger Points” Points” CBCCBC
– WBC <5.0, abs neutro <WBC <5.0, abs neutro <1,7501,750, bands >2.0, bands >2.0– I/T ratio > I/T ratio > 0.2*0.2*– Platelets < 100,000Platelets < 100,000
CRP > 1.0 mg/dlCRP > 1.0 mg/dl CSF > 20 WBC’s with few or no RBC’s CSF > 20 WBC’s with few or no RBC’s Radiographs: infiltrates on CXR, ileus Radiographs: infiltrates on CXR, ileus
on KUB, periosteal elevation, etc.on KUB, periosteal elevation, etc.
TreatmentTreatment PreventionPrevention – vaccines, GBS – vaccines, GBS
prophylaxis, HAND-WASHINGprophylaxis, HAND-WASHING SupportiveSupportive – respiratory, metabolic, – respiratory, metabolic,
thermal, nutrition, monitoring drug thermal, nutrition, monitoring drug levels/toxicitylevels/toxicity
SpecificSpecific – antimicrobials, immune – antimicrobials, immune globulinsglobulins
Non-specificNon-specific – IVIG, NO inhibitors & – IVIG, NO inhibitors & inflammatory mediatorsinflammatory mediators
Neonatal Sepsis:Neonatal Sepsis:the special case ofthe special case of
Group B Strep Group B Strep SepsisSepsis
RISK FACTORSRISK FACTORS Gestational ageGestational age Maternal well-beingMaternal well-being Ruptured membranes > 18 hoursRuptured membranes > 18 hours Location of deliveryLocation of delivery Infant/Fetal symptomatologyInfant/Fetal symptomatology Clinical suspicionClinical suspicion
GBS SGBS SEPSISEPSIS
Mothers in labor or Mothers in labor or with ROM with ROM should be should be treated treated if:if: ChorioamnionitisChorioamnionitis History of previous GBS+ baby History of previous GBS+ baby Mother GBS+ or GBS-UTI this preg.Mother GBS+ or GBS-UTI this preg. Mother’s GBS status unknown and:Mother’s GBS status unknown and:
– < 37 wks gestation< 37 wks gestation– ROM ROM ≥≥ 18 hrs 18 hrs– Maternal temp Maternal temp ≥≥ 38 38o o (100.4(100.4ooF)F)
INFANTS TO BE SCREENEDINFANTS TO BE SCREENED Maternal “chorioamnionitis”Maternal “chorioamnionitis” Maternal illness Maternal illness (i.e. UTI, pneumonia)(i.e. UTI, pneumonia) Maternal peripartum fever > 38Maternal peripartum fever > 38oo
(100.4(100.4ooF)F) Prolonged ROM Prolonged ROM ≥≥ 18 hrs ( 18 hrs (≥≥ 12 hrs 12 hrs
preterm)preterm) Mother GBS+ with inadequate Mother GBS+ with inadequate
treatment (treatment (< 4 hrs< 4 hrs))– No screening necessary if C-section delivery No screening necessary if C-section delivery
with intact membraneswith intact membranes
GBS SGBS SEPSISEPSIS
INFANTS TO BE SCREENEDINFANTS TO BE SCREENED Prolonged labor (> 20 hrs)Prolonged labor (> 20 hrs) Home or contaminated deliveryHome or contaminated delivery ““Chocolate-colored”/foul smelling Chocolate-colored”/foul smelling
amniotic fluidamniotic fluid Persistent fetal tachycardiaPersistent fetal tachycardia SYMPTOMATIC INFANTSYMPTOMATIC INFANT
– treat immediately (in DR if possible)treat immediately (in DR if possible)
GBS SGBS SEPSISEPSIS
SEPSIS SCREENSEPSIS SCREEN CBC with differentialCBC with differential Platelet countPlatelet count Blood culture x 1 (ideally 1 ml)Blood culture x 1 (ideally 1 ml) Chest X-ray &/or LP if Chest X-ray &/or LP if
symptomaticsymptomatic Close observation and frequent Close observation and frequent
clinical evaluationclinical evaluation Role of CRPRole of CRP
GBS SGBS SEPSISEPSIS
* CBC, blood cx, & CXR if resp sx. If ill consider LP.++ Duration of therapy may be 48 hrs if no sx.$ CBC with differential and blood culture# Applies only to penicillin, Ampicillin, or cefazolin. ** If healthy & ≥ 38 wks & mother got ≥ 4 hours IAP, may D/C at 24 hrs.
Maternal antibiotics for suspectedchorioamnionitis?
Duration of IAPbefore delivery
< 4 hours #
Full diagnostic evaluation *Empiric therapy++
Limited evaluation$ & Observe ≥ 48 hoursIf sepsis is suspected, full diagnostic evaluation and empiric therapy ++
Gestational age
<35 weeks?
No evaluation No therapyObserve ≥ 48 hours**
Maternal Rx for GBS?
Signs of neonatal sepsis?
Algorithm for Neonate whose Mother Received Intrapartum Antibiotics
Careful Observation&
Immediate Antibiotics
Careful Observation pending review of
screen
• Symptomatic INFANT• Maternal intrapartum fever > 38.6o
• “Chocolate” or foul smelling fluid• Ill mother
• Fetal tachycardia • Home delivery• Maternal fever < 38.6o
• PROM • Mat GBS with < 2 dose abx
(-) Screen (+) Screen (-) Screen (+) Screend/c abx; careful obs and monit bld cx until d/c
Cont abx until bld cx neg for 48o if asympt. Use clini-cal judgement for cessation of abx if pt is/was sympt
Careful obs and monit bld cx until d/c
Initiate abx & cont until bl cx (-) for 48o. Clinical judgement for cessation of abx if pt sympt
Initiate, resume or continue abx therapy and treat for 7-10 days for gram pos organism or longer if gram neg organism cultured. LP may be performed at the discretion of
attending, especially in seriously symptomatic pt
Blood Culture Positive
SSEPSISEPSIS
SIGNS and SYMPTOMSSIGNS and SYMPTOMS temp instabilitytemp instability • lethargy • lethargy poor feeding/residualspoor feeding/residuals • resp distress • resp distress glucose instabilityglucose instability • poor • poor
perfusionperfusion hypotensionhypotension • bloody stools • bloody stools abdominal distentionabdominal distention • bilious • bilious
emesisemesis apneaapnea • tachycardia • tachycardia skin/joint findingsskin/joint findings
LABORATORY EVALUATIONLABORATORY EVALUATION Provide added value when results are Provide added value when results are
normalnormal– high negative predictive valuehigh negative predictive value– low positive predictive valuelow positive predictive value
abnl results could be due to other reasons and not abnl results could be due to other reasons and not infectioninfection
IT < 0.3, ANC > 1,500 (normal) do not start IT < 0.3, ANC > 1,500 (normal) do not start abx, or d/c abx if started, if pt remains abx, or d/c abx if started, if pt remains clinically stableclinically stable
IT IT >> 0.3, ANC < 1,500 consider initiation of 0.3, ANC < 1,500 consider initiation of abx pending bld cx in “at-risk” pt who was abx pending bld cx in “at-risk” pt who was not already begun on antibiotics for other not already begun on antibiotics for other factorsfactors
SSEPSISEPSIS
LABORATORY EVALUATIONLABORATORY EVALUATION Positive screenPositive screen
– total WBC total WBC << 5,000 5,000 – – I/T I/T >> 0.3 0.3– ANC ANC << 1,500 1,500 – platelets < 100,000– platelets < 100,000
Additional work-upAdditional work-up– CXR, urine cx, and LP as clinically indicatedCXR, urine cx, and LP as clinically indicated
CRPCRP– no added value for diagnosis of early onset no added value for diagnosis of early onset
sepsissepsis– best for best for negativenegative predicativepredicative valuevalue or when or when
used seriallyused serially– notnot to be used to decide about rx, duration of to be used to decide about rx, duration of
rx or need for LPrx or need for LP– positive results for a single value obtained at positive results for a single value obtained at
24 hrs ranges > 4.0 - 10.0 mg/dL24 hrs ranges > 4.0 - 10.0 mg/dL
SSEPSISEPSIS
SSEPSISEPSISTREATMENTTREATMENT Review protocolReview protocol AntibioticsAntibiotics
– Ampicillin 100 mg/kg/dose IV q 12 hoursAmpicillin 100 mg/kg/dose IV q 12 hours– Gentamicin 3.5 mg/kg/dose IV q 24 hoursGentamicin 3.5 mg/kg/dose IV q 24 hours
IM route may be used in asymptomatic pt on IM route may be used in asymptomatic pt on whom abx are initiated for maternal risk factors whom abx are initiated for maternal risk factors or or to avoid delays to avoid delays when there is difficulty when there is difficulty obtaining IVobtaining IV
– For meningitis: Ampicillin 200-300 mg/kg/dFor meningitis: Ampicillin 200-300 mg/kg/d Symptomatic managementSymptomatic management
– respiratory, cardiovascular, fluid supportrespiratory, cardiovascular, fluid support
PrognosisPrognosis
Fatality rate 2-4 times higher in Fatality rate 2-4 times higher in LBW than in term neonatesLBW than in term neonates
Overall mortality rate 15-40%Overall mortality rate 15-40% Survival less likely if also Survival less likely if also
granulocytopenic (I:T > 0.80 granulocytopenic (I:T > 0.80 correlates with death and may correlates with death and may justify granulocyte transfusion).justify granulocyte transfusion).